Literature DB >> 1680305

Excitatory amino acids in amyotrophic lateral sclerosis: an update.

J D Rothstein, R Kuncl, V Chaudhry, L Clawson, D R Cornblath, J T Coyle, D B Drachman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1680305     DOI： 10.1002/ana.410300223

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  16 in total

Review 1.  Motor neuron disease: etiology, pathogenesis and treatment--a review.

Authors:  D J Donohoe; B Brady
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

Review 2.  MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.

Authors:  Paola Rinchetti; Mafalda Rizzuti; Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

Review 3.  Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Andrea Diana; Rita Pillai; Paolo Bongioanni; Aidan G O'Keeffe; Robert G Miller; Dan H Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-01-09

4.  N-acetylaspartic acid (NAA) and N-acetylaspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid.

Authors:  K F Faull; R Rafie; N Pascoe; L Marsh; A Pfefferbaum
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

Review 5.  MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.

Authors:  Frank Cloutier; Alier Marrero; Colleen O'Connell; Pier Morin
Journal:  J Mol Neurosci       Date:  2014-11-30       Impact factor: 3.444

6.  MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis.

Authors:  B C Bowen; P M Pattany; W G Bradley; J B Murdoch; F Rotta; A A Younis; R C Duncan; R M Quencer
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

Review 7.  Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Lucas T Vu; Robert Bowser
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 8.  The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  Amy Cameron Ellis; Jeffrey Rosenfeld
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.

Authors:  J D Rothstein; L Jin; M Dykes-Hoberg; R W Kuncl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 10.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.